What is a DSMB?
A Data Safety Monitoring Board (DSMB), also known as a Data Monitoring Committee (DMC) or Independent Data Monitoring Committee (IDMC), is an independent group of experts responsible for monitoring the safety and efficacy of a clinical trial while it is ongoing. The primary role of the DSMB is to ensure the well-being of study participants and to maintain the scientific integrity of the trial.
Essential functions and responsibilities of a Data Safety Monitoring Board
Safety Monitoring: The DSMB regularly reviews safety data from the clinical trial to identify potential safety concerns or adverse events that may be related to the study intervention. Their primary focus is on the safety of trial participants.
Interim Analysis: The DSMB conducts pre-planned interim analyses of the accumulating trial data at specific time points or after a certain number of participants have completed the study. These analyses assess whether the study should continue as planned or if there are compelling reasons to modify or terminate the trial early.
Treatment Efficacy and Futility: Besides safety, the DSMB evaluates the treatment efficacy and overall trial progress. They may assess whether the treatment shows significant efficacy or whether the study is unlikely to achieve its primary objective (futility analysis).
Unblinding and Decision Making: The DSMB can access unblinded data to conduct its analyses. However, if pre-specified stopping boundaries are met, they keep the results confidential and only communicate relevant findings to the trial’s investigators or sponsors.
Recommendations: Based on their analyses, the DSMB may provide recommendations to the trial’s steering committee or sponsors. These recommendations can include modifications to the study protocol, changes to the sample size, early termination, or continuation of the trial as planned.
Independence: The DSMB must be independent of the investigators, sponsors, and study team to ensure an unbiased evaluation of the trial data. Their independence helps maintain the integrity and objectivity of the monitoring process.
Expertise: The DSMB comprises experts in relevant fields, such as clinical medicine, radiology, biostatistics, and ethics, who must be able to evaluate trial data effectively and efficiently.
Why DSMB activities are important
Establishing a Data Safety Monitoring Board is especially important for significant, long-term clinical trials involving vulnerable populations or high-risk interventions. It helps protect the welfare of study participants, ensures that the trial is conducted ethically, and enhances the credibility and validity of the study’s results. The DSMB’s role is to objectively assess the accumulating data and make informed recommendations to ensure the trial’s success and safety.
Contact us to support your DSMB trial efforts
Biomedical Statistical Consulting routinely advises and provides blinded and unblinded DSMB roles, including the development of DSMB reports. Contact us to learn more.
Congratulations to BSC®’s David Maislin, Alex Breno, and our friends at 3Spine on their recent publication!
The article lays out the protocol for the pivotal IDE trial behind 3Spine's MOTUS® lumbar Total Joint Replacement, the first device built to restore both disc and facet joint function without sacrificing motion.
WHAT CLIENTS SAY
“They listen the first time. I’ve never had to go back and respell out what I needed."
”They work to understand the problem and leverage the information that is already there.”
Former FDA Regulator
WHAT CLIENTS SAY
"Battle ground tested."
"There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”
Vice President, Clinical Operations
WHAT CLIENTS SAY
"Get stuff done when you have to do something no one else has done before."
"They aren’t afraid to tackle difficult scenarios in compressed timelines."
CEO, Medical Device Company
Regulatory-first biostatistics
Support built specifically for FDA-facing programs, from early feasibility through submission and post-market requirements.
Direct communication, faster turn around
Our biostatisticians write the SAP and run the analysis. One person owns both — no separate programmer, no project manager in between.
Versatile Solutions
Engage us for a focused analysis or a full submission, We size the work to the problem.
Proven FDA Experience
Hands-On Experience with FDA Pathways, statistical reviews, and regular interactions, reducing risk and rework.










